Sutro biopharma announces presentation of stro-002 data from the compassionate use program in pediatric patients with relapsed/refractory cbf/glis aml at ash 2022

– A total of 17 pediatric patients were treated with STRO-002 on a compassionate use basis; eight patients achieved complete remission, of which sev...

December 10, 2022, 3:30 pm

Mercadolibre: mercado pago, a truly fascinating business

As a first-mover, the management capitalized on the massive underbanked/unbanked populations in Latin A...

December 10, 2022, 6:42 am

Tesla begins selling cars in thailand, a growing electric vehicle hotspot

Southeast Asia boasts a population of over 600 million, providing a significantly untapped market for c...

December 9, 2022, 1:59 pm

Erasca announces exclusive worldwide license for pan-raf inhibitor naporafenib

Concurrent $100 million equity offering Naporafenib has a potential first-in-class and best-in-class profile in multiple RAS/MAPK pathway-driven tumor...

December 9, 2022, 12:34 pm

Just some supplementary covid measures being announced from china today it seems

It isn't much as the NHC just released some supplementary guidelines as noted below:

...

December 8, 2022, 7:23 am

Why china's healthcare sector might be the real reopening play

China continues to roll back its COVID-19 zero-tolerance policy, lifting many ongoing quarantines and removing testing requirements that previously pr...

December 7, 2022, 6:59 pm

Gossamer bio tumbles as hypertension drug underperforms rival product in phase 2 trial

Gossamer Bio Inc stock lost three quarters of its value today as the market questioned the performance of the company's experimental hypertension dru...

December 6, 2022, 2:54 pm

Meta platforms: metaverse a weak spot; still a buy!

The stock price of Meta Platforms has dropped 75% from recent highs, making us wonder if Mr. Market is presenting an opportunity for investors. Althou...

December 5, 2022, 2:22 pm

Flowers foods is not appetizing at these levels

The gluten-free diet trend has been around for at least several decades as studies have found that eating gluten can negatively affect some people's h...

November 30, 2022, 3:46 pm

Gilead (gild) gets ec approval for biktarvy label expansion

Gilead (GILD) gets EC authorization for Biktarvy for the treatment of HIV in pediatric populations....

November 30, 2022, 9:02 am

Tipping scale for crypto adoption: usability vs. accessibility

One of the biggest problems associated with the ...

November 29, 2022, 11:01 am

Rba gov. lowe says demand is too strong relative to supply

From Reserve Bank of Australia Governor Lowe, his appearance before the Australian parliament's Senate Economics Legislation Committee (Additional ...

November 27, 2022, 11:24 pm

6g mobile investment launched by ericsson as planning for 2030 rollout steps up

Despite ill-founded rumours that it is linked to Covid, the roll-out of 5G mobile has reached less than a third of the world's ...

November 22, 2022, 8:06 am

A green hydrogen bet, gm expects ev profits by 2025 and the world's population hits 8 billion

This week's Current Climate, which every Saturday brings you the latest news about the business of sustainability....

November 19, 2022, 8:00 am

Bhp group: in the midst of a transformation

BHP Group Limited is transforming the company to align with the narrative of a growing population and c...

November 18, 2022, 1:40 pm

G20: what did the leaders decide?

The G20 summit took place in Bali, Indonesia, on November 2022. Industrialized and developing countries of the G20 account for 80% of global economic ...

November 17, 2022, 4:30 pm

Editas medicine announces clinical data demonstrating proof of concept of edit-101 from phase 1/2 brilliance trial

EDIT-101 demonstrates a favorable safety profile across all dose cohorts Preliminary efficacy signals of consistent improvement in BCVA plus additiona...

November 17, 2022, 12:15 pm

Growth of climate etfs could stir interest in clnr

The exponential growth of the population of environmental, social, and governance (ESG) funds in recent...

November 17, 2022, 11:08 am

Barron’s: global ultrahigh-net-worth population has fallen in 2022 — first decline in four years

This superwealthy slice of the U.S. population was 10.3% smaller in the first six months of 2022 than i...

November 12, 2022, 11:10 am

Neuronascent to present further nni-362 phase1a data at ctad 2022 for alzheimer’s disease

ROCKVILLE, Md., Nov. 08, 2022 (GLOBE NEWSWIRE) — Neuronascent Inc., today announced its abstract entitled “Reduction of plasma p-Tau181 from a Pha...

November 8, 2022, 11:00 am